20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
The Setting Every Community Up For Retirement Enhancement (“SECURE”) Act, which was enacted into l...
Read More >
On 23 October 2019, the UK Supreme Court decided that Professor Ian Shanks, a former employee of Uni...
Read More >
The Fifth Circuit concluded that a plan’s three-year contractual limitations period began to accrue...
Read More >
Medical Provider Refused to Hire Men and Retaliated Against an Applicant for Complaining, Federal Ag...
Read More >
We’re excited to introduce Navigating, a new webcast series created to assist clients and friends o...
Read More >
In this episode of Trekking Through Compliance, we consider the episode The Paradise Syndrome which ...
Read More >